MedPath

Pain Killer, Anxiety and Mucogingival Therapy

Not Applicable
Recruiting
Conditions
Anxiety and Depression
Interventions
Procedure: gingival graft
Registration Number
NCT05747092
Lead Sponsor
University of Liege
Brief Summary

Is the pain killer consumption after gingival treatment related to the level of patient anxiety or to the type of therapy?

Detailed Description

Anxiety and depression (HAD) scale used could be reveal the level of the patient anxiety and/or depression before intervention.

Additionnaly the use of these specific questionnaires (7 items for anxiety, 7 items for depression) could reveal if the pain killer consumption after gingical treatment is dependant to the level of HAD or to the therapy .

This tool (HAD) could allows to recognize, before any (oral)surgery, profil with high risk and propose solution to decrease anxiety and/or depression before treatment.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • ASA type I and II subjects
  • Localized Gingival Recessions
  • Recessions Cairo RT I-II
  • FMPS < 10%
  • FMBS< 10%
  • <10 cigs/ day
  • No contra-indication against oral surgical interventions
  • Patient is able to give inform consent
Exclusion Criteria
  • Infection (local or systemic). Each infection will be evaluated prior to study procedure for suitability. Patients with gingivitis or local infection (fracture, apical reaction) will undergo a dental treatment prior to his entrance to the study. In case of systemic infection, the evaluation will be based on medical anamneses, and if necessary will be referred to relevant medical tests.
  • ASA type > II
  • Current pregnancy or breastfeeding women
  • Alcoholism or chronically drug abuse
  • Smokers, ≳ 10 cigarettes per day
  • Immunocompromised patients
  • Uncontrolled diabetes
  • Untreated periodontitis
  • History of previous periodontal surgery (mucogingival or other) on the teeth to be included
  • Presence of severe tooth malposition, rotation or significant version of the tooth to be treated

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Test group: connective tissue graft for gingival recessiongingival graft-
Control group: free gingival graft for gingival recessiongingival graft-
Primary Outcome Measures
NameTimeMethod
pin killer consumptiontwo weeks

the number of pain killer used after treatment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

leila Salhi

🇧🇪

Liège, Liege, Belgium

© Copyright 2025. All Rights Reserved by MedPath